Linagliptin

Linagliptin Is Active Ingredient, An Orally Active Inhibitor Of The Dipeptidyl Peptidase-4 (Dpp-4) Enzyme. Treating Type 2 Diabetes In Patients Who Cannot Control Blood Sugar Levels By Diet And Exercise Alone. It Is Used Along With Diet And Exercise. It May Be Used Alone Or With Other Antidiabetic Medicines. It Works By Increasing The Amount Of Insulin Released By Your Body And Decreasing The Amount Of Sugar Made By Your Body. Linagliptin Is A Potent, Orally Bioavailable Dihydropurinedione-based Inhibitor Of Dipeptidyl Peptidase 4 (Dpp-4), With Hypoglycemic Activity. The Inhibition Of Dpp-4 By Linagliptinappears To Be Longer Lasting Than That By Some Other Dpp-4 Inhibitors Tested.

Details

• Synynoms -  1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2quinazolinyl) Methyl]
• Cas Number - 668270-12-0
• Molecular Formula -  C25h28n8o2 And The Molecular Weight Is 472.54 G/mol.
• Linagliptin is a white to yellowish, Not Or Only Slightly Hygroscopic Solid Substance. It Is Very Slightly Soluble In Water (0.9 Mg/ml). It Has Melting Point 202°C
• Standard - Offered Of Pharmaceutical Grade BP/USP/EP
• Packing - Offered In Export Worthy Packing Of 5 Kilos Or As Per Our Customer Requirements.